209 related articles for article (PubMed ID: 28423608)
21. Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy.
Martiniova L; Lu J; Chiang J; Bernardo M; Lonser R; Zhuang Z; Pacak K
PLoS One; 2011 Feb; 6(2):e14678. PubMed ID: 21339823
[TBL] [Abstract][Full Text] [Related]
22. NF-κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model.
Pacak K; Sirova M; Giubellino A; Lencesova L; Csaderova L; Laukova M; Hudecova S; Krizanova O
Int J Cancer; 2012 Nov; 131(10):2445-55. PubMed ID: 22407736
[TBL] [Abstract][Full Text] [Related]
23. HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas.
Bechmann N; Moskopp ML; Ullrich M; Calsina B; Wallace PW; Richter S; Friedemann M; Langton K; Fliedner SMJ; Timmers HJLM; Nölting S; Beuschlein F; Fassnacht M; Prejbisz A; Pacak K; Ghayee HK; Bornstein SR; Dieterich P; Pietzsch J; Wielockx B; Robledo M; Qin N; Eisenhofer G
Endocr Relat Cancer; 2020 Nov; 27(11):625-640. PubMed ID: 33112842
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors.
Toledo R; Jimenez C
F1000Res; 2018; 7():. PubMed ID: 30109021
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma.
Span PN; Rao JU; Oude Ophuis SB; Lenders JW; Sweep FC; Wesseling P; Kusters B; van Nederveen FH; de Krijger RR; Hermus AR; Timmers HJ
Endocr Relat Cancer; 2011 Jun; 18(3):323-31. PubMed ID: 21422080
[TBL] [Abstract][Full Text] [Related]
26. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2
Pang Y; Gupta G; Yang C; Wang H; Huynh TT; Abdullaev Z; Pack SD; Percy MJ; Lappin TRJ; Zhuang Z; Pacak K
BMC Cancer; 2018 Mar; 18(1):286. PubMed ID: 29534684
[TBL] [Abstract][Full Text] [Related]
27. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.
Loriot C; Burnichon N; Gadessaud N; Vescovo L; Amar L; Libé R; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2012 Jun; 97(6):E954-62. PubMed ID: 22492777
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
[TBL] [Abstract][Full Text] [Related]
29. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
31. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.
Xekouki P; Brennand A; Whitelaw B; Pacak K; Stratakis CA
Horm Metab Res; 2019 Jul; 51(7):419-436. PubMed ID: 30273935
[TBL] [Abstract][Full Text] [Related]
32. New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas.
Toledo RA
Endocr Relat Cancer; 2017 Sep; 24(9):C9-C19. PubMed ID: 28667082
[TBL] [Abstract][Full Text] [Related]
33. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
[TBL] [Abstract][Full Text] [Related]
34. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
36. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
[TBL] [Abstract][Full Text] [Related]
37. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression.
Camenisch G; Stroka DM; Gassmann M; Wenger RH
Pflugers Arch; 2001 Nov; 443(2):240-9. PubMed ID: 11713650
[TBL] [Abstract][Full Text] [Related]
39. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells.
Warnecke C; Zaborowska Z; Kurreck J; Erdmann VA; Frei U; Wiesener M; Eckardt KU
FASEB J; 2004 Sep; 18(12):1462-4. PubMed ID: 15240563
[TBL] [Abstract][Full Text] [Related]
40. A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy.
Pacak K; Kidd M; Meuter L; Modlin IM
Endocr Relat Cancer; 2021 Oct; 28(11):731-744. PubMed ID: 34515661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
